Locoid 0.1% Lipocream

Land: Storbritannien

Sprog: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiv bestanddel:

Hydrocortisone butyrate

Tilgængelig fra:

Neon Healthcare Ltd

ATC-kode:

D07AB02

INN (International Name):

Hydrocortisone butyrate

Dosering:

1mg/1gram

Lægemiddelform:

Cutaneous cream

Indgivelsesvej:

Cutaneous

Klasse:

No Controlled Drug Status

Recept type:

Valid as a prescribable product

Produkt oversigt:

BNF: 13040000; GTIN: 5013346026783 5013346026790

Indlægsseddel

IAT001 (LFT293) Page 1+2, 145x270 mm
145 mm
270 mm
PACKAGE LEAFL ET: INFORMATION FOR THE USER
LOCOID LIPOCREAM
®
Hydrocortisone butyrate 0.1% w/w
053058
READ ALL OF THIS LEAFL ET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
•
Keep this leafl et. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their
signs of illness are the same as yours.
•
If you get any side eff ects, talk to your doctor, pharmacist or
nurse. This includes any possible side eff ects
not listed in this leafl et. See section 4.
WHAT IS IN THIS LEAFL ET:
1.
What Locoid Lipocream is and what it is used for
2.
What you need to know before you use Locoid Lipocream
3.
How to use Locoid Lipocream
4.
Possible side eff ects
5.
How to store Locoid Lipocream
6.
Contents of the pack and other information
1. WHAT LOCOID LIPOCREAM IS AND WHAT IT IS USED FOR
Locoid Lipocream contains the active substance hydrocortisone
butyrate. This is a corticosteroid which
when made up as a cream is for use on the skin. This is known as
topical application. Topical corticosteroids
are ranked as mildly potent, moderately potent, potent and very
potent; Locoid Lipocream is classed as
potent. Topical corticosteroids are able to reduce the infl ammation
caused by a variety of skin conditions,
and so allow it to get better. They can also aff ect the cause of the
condition, which can lead to its healing.
Locoid Lipocream is indicated in adults, children and infants. It is
used to treat a variety of skin conditions
that respond to topical corticosteroids. Among these are eczema and
dermatitis (itching) of all types
including atopic (childhood) eczema, photodermatitis (itching caused
by exposure to light) and dermatitis
caused by skin irritants and allergies.
It can also be used in the treatment of psoriasis, a condition
resulting in thickening of areas of the sk

Produktets egenskaber

OBJECT 1
LOCOID LIPOCREAM
Summary of Product Characteristics Updated 15-Sep-2016 | Leo
Laboratories Limited
1. Name of the medicinal product
Locoid Lipocream
2. Qualitative and quantitative composition
Locoid Lipocream contains 0.1% w/w hydrocortisone butyrate.
Excipient(s) with known effect:
Cetostearyl alcohol (6% w/w)
Propyl parahydroxybenzoate (E216) (0.05% w/w)
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Cream.
The product is a white cream with a high percentage (about 70%) of
fats and oils.
4. Clinical particulars
4.1 Therapeutic indications
Locoid Lipocream is indicated in adults, children and infants. The
product is recommended for clinical
use in the treatment of conditions responsive to topical
corticosteroids e.g. eczema, dermatitis and
psoriasis.
Topical corticosteroids are not generally indicated in psoriasis but
may be acceptable in psoriasis
excluding widespread plaque psoriasis provided warnings are given; see
section 4.4 Special warnings and
precautions for use.
4.2 Posology and method of administration
Posology
_Adults and older people_
The same dose is used for adults and older people, as clinical
evidence would indicate that no special
dosage regimen is necessary in the elderly.
_Paediatric population_
Long term treatment should be avoided where possible.
_Infants_
Therapy should be limited if possible to a maximum of seven days.
Method of administration
For cutaneous use.
Dosage: To be applied evenly and sparingly no more than twice daily
Application may be made under occlusion in the more resistant lesions
such as thickened psoriatic
plaques on elbows and knees.
Due to the formulation of the base the product may be used both for
dry scaly lesions and for moist or
weeping lesions.
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
This preparation is contraindicated in the presence of untreated viral
or fungal infections, tubercular or
syphilitic lesions, peri-oral dermatitis, acne vulgaris and rosacea